Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke

@inproceedings{Ogawa2007RandomizedTO,
  title={Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke},
  author={Akira Ogawa and Etsuro Mori and Kazuo Minematsu and Waro Taki and A. S. C. Takahashi and Shigeru Nemoto and Susumu Miyamoto and Makoto Sasaki and Takashi Inoue},
  year={2007}
}
Background and Purpose—The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy of intraarterial infusion of urokinase (UK) in patients with stroke within 6 hours of onset. Methods—Patients with ischemic stroke presenting within 6 hours of onset and displaying… CONTINUE READING